Evolução dos índices de proliferação celular e apoptose em placentas de ratas com diabete grave: relação com glicemia materna e o resultado perinatal

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Análise morfológica e imunológica das placentas de ratas com diabete de intensidade moderada

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Diabete e gravidez: estudo prospectivo do custo benefício da hospilização comparado com atenção ambulatorial

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Evolução da curva de altura uterina em gestações complicadas por diabete e hiperglicemia leve

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Efeito do diabete moderado na matriz extravelular e no músculo estriado uretral em ratas prenhez

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Expressão e imunidade das Heat Shock Proteins (HSP) em gestantes portadoras de diabete e hiperglicemia gestacional leve

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Imunologia das interações materno-fetais no diabete e na hiperglicemia gestacional leve

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Efeito do diabete induzido por streptozotocin na matriz extracelular e no músculo estriado uretral em ratas prenhes

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Diabete moderado induzido em diferentes fases da vida de ratas Wistar: repercussões na reprodução materna e na freqüência de anomalias fetais

Experimental models are necessary to elucidate pathophysiological mechanisms not yet understood in humans. To evaluate the repercussions of the diabetes, considering two methodologies, on the pregnancy of Wistar rats and on the development of their offspring. In the 1st induction, female offspring were distributed into two experimental groups: Group streptozotocin (STZ, n=67): received the β-cytotoxic agent (100mg STZ/kg body weight - sc) on the 1st day of the life; and Non-diabetic Group (ND, n=14): received the vehicle in a similar time period. In the adult life, the animals were mated. After a positive diagnosis of pregnancy (0), female rats from group STZ presenting with lower glycemia than 120 mg/dL received more 20 mg STZ/kg (ip) at day 7 of pregnancy (2nd induction). The female rats with glycemia higher than 120mg/dL were discarded because they reproduced results already found in the literature. In the mornings of days 0, 7, 14 and 21 of the pregnancy glycemia was determined. At day 21 of pregnancy (at term), the female rats were anesthetized and killed for maternal reproductive performance and fetal development analysis. The data were analyzed using Student-Newman-Keuls, Chi-square and Zero-inflated Poisson (ZIP) Tests (p<0.05). STZ rats presented with increased rates of pre (STZ=22.0%; ND=5.1%) and post-implantation losses (STZ=26.1%; ND=5.7%), reduced rates of fetuses with appropriate weight for gestational age (STZ=66%; ND=93%) and reduced degree of development (ossification sites). Conclusion: Mild diabetes led a negative impact on maternal reproductive performance and caused intrauterine growth restriction and impaired fetal development

IL-10 e TNF-α no sangue materno e nas placentas de gestações complicadas por diabete ou hiperglicemia gestacional leve - correlação com controle glicêmico e resultados perinatais

Objective - At evaluating the IL-10 production in maternal blood and placenta and correlate them with perinatal outcomes in pregnancies complicated by hyperglycemia, or with risk to developing it, differentiated by the glycemic mean (GM < or ≥ 100mg/dL). Method- 186 pregnant women were distributed into groups GM < 100 mg/dL and GM ≥ 100 mg/dL. We evaluated the GM, HbA1c levels, maternal and placental IL-10 and TNF-α and the correlation between placental cytokines and perinatal outcomes. Results - In maternal blood, the lower concentrations of IL-10 (1.01 ± 0.87 vs. 3.08 ± 5.57 pg / mL, p = 0.0019) were observed in GM ≥ 100 mg / dL group. Placental IL-10 was directly correlated with hemoglobin levels (r = 0.63, p = 0.02) and insulin (r = 0.78, p = 0.01) from umbilical cord and with Apgar scores 1 (r = 0.53, p = 0.0095) and Apgar 5 (r = 0.69, p = 0.0003). Conclusion - GM ≥ 100mg/dL was associated with decreased of maternal IL-10. Placental IL-10 was similar in both groups and correlated directly with hemoglobin and insulin and with Apgar scores of 1st. and 5th. minutes

Atividade física na gestação: aplicabilidade de um questionário específico para gestantes (PPAQ) e sua associação com Diabete Melito Gestacional (DMG), sobrepeso/obesidade

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Qualidade de vida e satisfação das gestantes portadoras de diabete em uso de insulina em hospital universitário do interior de São Paulo

Pós-graduação em Ginecologia, Obstetrícia e Mastologia - FMB

Polimorfismo do colágeno tipo 3 e da metaloproteinase 9 como fator de risco para a incontinência em muheres com diabete mellitus gestacional

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Doença periodontal, diabete mellitus e hipertensão em gestantes usuárias do Sistema Único de Saúde (SUS)

Purpose: To evaluate the association among periodontal disease, diabetes mellitus and arterial hypertension in pregnant women users of the Brazilian Health System (SUS). Methods: The sample consisted of 86 women, with pregnant age between the 4th and 7 th month, submitted to pre-natal attendance in Health Basic Unities (HBUs). Periodontal condition was evaluated by 2 calibrated researchers (Kappa = 0.91) through the Community Periodontal Index (CPI). A sphygmomanometer was used to check the arterial pressure, what was accomplished by the professionals from the HBUs; glycemia test was accomplished through a blood sample collected from the middle finger with a disposable lancet adapted to a lance device (Accu-Chek Softclix Pro; Roche, USA), and for checking the glycemia level, a glycemia monitor was used (Accu-Chek Advantage II, Roche, USA). Data were written on a numbered register form, avoiding patient identification. After, the same data were statistically analyzed through the Fisher Exact Test, in order to evaluate the existence of association between the variables blood glucose and periodontal disease. In this test, a significance level of 0,05 was adopted. Results – Most of the pregnant woman presented periodontal health (58,1%); 41,9% of the research subjects showed at least one sign of periodontal disease, with 31,4% presenting gingivitis and 10,5% periodontitis. Hyperglycemia was detected in 51,2% and it was not found a value of arterial pressure higher than what is considered to be normal. Conclusion: it was not verified a significant association among the presence of periodontal disease, glycemia alteration and arterial hypertension in pregnant women who comprised this research.

Acompanhamento nutricional no Diabete Melito gestacional

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance, star or first recognitition during pregnancy, has whith a treatment strategyof monitoring the proper nutrition. During prenatal care, nutrition recommendationsare directed to two foci, energy consumption and maternal weight gain. Thus, adequate enrgy intake results in a aqquate maternal weight gain, ensuring the needs of the fetus. Nutrition interventions is na ally in control of GDM, bringing benefits to maternal and fetal health. In the assessment of maternal nutrition state be emploved antropometric, dietary, biochemical and clinical. The dietary assessment should be detailed, with attencion to fractionation and composition of meals, grifts and food groups. The nutritional monitoring in gestational diabetes aims to achieve normoglycemia and prevent metabolic and cardiovascular risks in the médium and long term, for mothers and their sons.